Literature DB >> 20553704

[Orofacial manifestations of systemic sclerosis: A study of 30 consecutive patients].

C Vincent1, C Agard, S Barbarot, J-M N'guyen, B Planchon, C Durant, M-A Pistorius, B Dreno, T Ponge, J-F Stalder, J-M Mercier, M Hamidou.   

Abstract

INTRODUCTION: The face is frequently involved in systemic sclerosis. The main stomatologic manifestations include limited mouth opening, xerostomia, skin atrophy, trigeminal neuralgia. The objective of this study was to describe oral and facial manifestations observed in scleroderma patients from our cohort.
METHODS: Between March and October 2006, a stomatologic consultation was included in the follow-up of scleroderma patients seen during consultation or daily hospital in internal medicine or dermatology units. Demographic, clinical and biological data were collected. Stomatologic examination comprised measure of the mouth opening, sugar's and Schirmer's tests, orthopantomogram analysis, and evaluation of the repercussion of symptoms on quality of life using a visual analogical scale (VAS between 0 and 10).
RESULTS: This study included 30 patients (women 87 %, mean age 58.6 + or - 13.6 years). Mean duration of systemic sclerosis (n=20 limited cutaneous form, n=10 diffuse form) was eight years. Stomatologic manifestations were: skin atrophy (n=28), peribuccal rhagades (n=25), telangiectasia (n=21), decreased mouth opening (n=20), xerostomia (n=20), xerophtalmia (n=16), periodontal ligament space widening (n=10), bone resorptions (n=2), trigeminal neuralgia (n=1). Xerostomia was considered more discomforting (mean VAS=3.8) than decreased mouth opening (mean VAS=2.6). Xerostomia was the second more discomforting sign of scleroderma and was significantly associated to the limited cutaneous form (p=0.045) and to anticentromeres antibodies expression (p=0.002). Decreased mouth opening was correlated to oesophageal involvement (p=0.025).
CONCLUSION: Oral and facial manifestations are frequently observed in scleroderma patients. These manifestations lead to major functional discomfort, mainly due to decreased mouth opening that seems to be frequently associated to oesophageal involvement. Xerostomia is also frequent and is commonly observed in anticentromere antibodies positive cutaneous limited forms of systemic sclerosis. Evolution of radiographic abnormalities like periodontal ligament space widening (33 % of cases), or osteolytic lesions (7 %) is poorly known. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20553704     DOI: 10.1016/j.stomax.2010.04.001

Source DB:  PubMed          Journal:  Rev Stomatol Chir Maxillofac        ISSN: 0035-1768


  8 in total

1.  Oral health: OHRQoL in systemic sclerosis.

Authors:  A Curto; D Curto; J Sanchez
Journal:  Br Dent J       Date:  2017-01-27       Impact factor: 1.626

2.  Instrumented Assessment of Oral Motor Function in Healthy Subjects and People with Systemic Sclerosis.

Authors:  Chiara Vitali; Cinzia Baldanzi; Francesca Polini; Angelo Montesano; Paola Ammenti; Davide Cattaneo
Journal:  Dysphagia       Date:  2015-02-17       Impact factor: 3.438

Review 3.  Orofacial consequences of systemic sclerosis: A systematic review.

Authors:  Rawen Smirani; Nicolas Poursac; Adrien Naveau; Thierry Schaeverbeke; Raphaël Devillard; Marie-Elise Truchetet
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

4.  The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population.

Authors:  Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Ernest Lo; Sabrina Gravel; Geneviève Gyger; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masseto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira-Filho; David Robinson; Mervyn Gornitsky
Journal:  Rheumatology (Oxford)       Date:  2014-01-24       Impact factor: 7.580

5.  The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population.

Authors:  Marie Dagenais; David MacDonald; Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Sabrina Gravel; Shrisha Mohit; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masseto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira-Filho; David Robinson; Mervyn Gornitsky
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-03-25

6.  Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature.

Authors:  Daniel N Reed; David L Hall; James H Cottle; Katherine Frimenko; Christina K Horton; Farah Abu Sharkh; Rachel Beckett; Brandon Hernandez; Hannah Mabe; Shadee T Mansour; Sebastian A Rodriguez; Bradley Weprin; Leigh E Yarborough
Journal:  Clin Case Rep       Date:  2020-01-17

7.  Fat Grafting Subjectively Improves Facial Skin Elasticity and Hand Function of Scleroderma Patients.

Authors:  Amy L Strong; Widya Adidharma; Owen H Brown; Paul S Cederna
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-25

8.  Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70).

Authors:  Ismet H Bajraktari; Avni Kryeziu; Fadil Sherifi; Halit Bajraktari; Ali Lahu; Genc Bajraktari
Journal:  Med Arch       Date:  2015-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.